Corrigendum to "Radio-protective effects of manganese-containing superoxide dismutase mimics on ataxia telangiectasia cells" [Free Radic. Biol. Med. 47/3 (2009) 250-260] (DOI:10.1016/j.freeradbiomed.2009.04.018);Radioprotective effects of manganese-containing superoxide dismutase mimics on ataxia-telangiectasia cells

Free Radical Biology and Medicine

Volumn 47, Issue 3, 2009, Pages 250-260

  Pollard, Julianne M ^a,b,c   Reboucas, Julio S ^d   Durazo, Armando ^b   Kos, Ivan ^d   Fike, Francesca ^b,c   Panni, Moeen ^e   Gralla, Edith Butler ^b   Valentine, Joan Selverstone ^b   Batinic Haberle, Ines ^d   Gatti, Richard A ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

AEOL10112; AEOL10113; Ataxia telangiectasia; EUK 134; EUK 189; EUK 8; Free radicals; M40403; M40404; Mn cyclic polyamines; Mn porphyrins; Mn salens; Radioprotection; SOD mimics

Indexed keywords

AEOL 10112; AEOL 10113; CELL DNA; EUK 189; HISTONE H2AX; M 40404; MANGANESE 5,10,15,20 TETRAKIS(N ETHYLPYRIDINIUM 2 YL)PORPHYRIN; MANGANESE 5,10,15,20 TETRAKIS(N HEXYLPYRIDINIUM 2 YL)PORPHYRIN; MANGANESE 5,10,15,20 TETRAKIS(N METHYLPYRIDINIUM 2 YL)PORPHYRIN; MANGANESE 5,10,15,20 TETRAKIS[N [1 [2 (2 METHOXYETHOXY)ETHOXY]ETHY]PYRIDINIUM 2 YL]PORPHYRIN; MANGANESE BETA OCTABROMO MESO TETRAKIS(4 SULFONATOPHENYL)PORPHYRIN; MANGANESE DERIVATIVE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MANGANESE SALEN CHLORIDE; MANGANESE SUPEROXIDE DISMUTASE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); RADIOPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFICACY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIPOPHILICITY; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; RADIOSENSITIVITY; WILD TYPE;

ATAXIA TELANGIECTASIA;

ANNEXIN A5; ANTIOXIDANTS; APOPTOSIS; ATAXIA TELANGIECTASIA; BIOMIMETIC MATERIALS; CELL SEPARATION; CELLS, CULTURED; COMET ASSAY; CYTOPROTECTION; FLOW CYTOMETRY; HUMANS; METALLOPORPHYRINS; PROPIDIUM; RADIATION-PROTECTIVE AGENTS; SUPEROXIDE DISMUTASE;

EID: 67349138879     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.004     Document Type: Erratum

References (67)

1. Dest V.M. Radioprotectants: adding quality of life to survivorship. Semin. Oncol. Nurs. 22 (2006) 249-256
2. Hosseinimehr S.J. Foundation review: trends in the development of radioprotective agents. Drug Discov. Today 12 (2007) 794-805
3. Mabro M., Faivre S., and Raymond E. A risk-benefit assessment of amifostine in cytoprotection. Drug Saf. 21 (1999) 367-387
4. Baier J.E., Neumann H.A., Moeller T., Kissler M., Borchardt D., and Ricken D. Radiation protection through cytokine release by N-acetylcysteine. Strahlenther Onkol. 172 (1996) 91-98
5. Cotrim A.P., Sowers A.L., Lodde B.M., Vitolo J.M., Kingman A., Russo A., Mitchell J.B., and Baum B.J. Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model. Clin. Cancer Res. 11 (2005) 7564-7568
6. Wan X.S., Ware J.H., Zhou Z., Donahue J.J., Guan J., and Kennedy A.R. Protection against radiation-induced oxidative stress in cultured human epithelial cells by treatment with antioxidant agents. Int. J Radiat. Oncol. Biol. Phys. 64 (2006) 1475-1481
7. Reliene R., and Schiestl R.H. Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice. J. Nutr. 137 (2007) 229S-232S
8. Vitolo J.M., Cotrim A.P., Sowers A.L., Russo A., Wellner R.B., Pillemer S.R., Mitchell J.B., and Baum B.J. The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin. Cancer Res. 10 (2005) 1807-1812
9. Batinić-Haberle I., Benov L., Spasojević I., and Fridovich I. The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J. Biol. Chem. 273 (1998) 24521-24528
10. Ferrer-Sueta G., Batinić-Haberle I., Spasojević I., Fridovich I., and Radi R. Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants. Chem. Res. Toxicol. 12 (1999) 442-449
11. Rebouças J.S., Defreitas-Silva G., Spasojević I., Idemori Y.M., Benov L., and Batinić-Haberle I. Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier. Free Radic. Biol. Med. 45 (2008) 201-210
12. - dismutation. J. Chem. Soc. Dalton Trans. 13 (2002) 2689-2696
13. Batinić-Haberle I., Spasojević I., Stevens R.D., Bondurant B., Okado-Matsumoto A., Fridovich I., Vujasković Z., and Dewhirst M.W. New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme. Dalton Trans. 4 (2006) 617-624
14. 5+, in plasma and major organs of B6C3F1 mice. Free Radic. Biol. Med. 45 (2008) 943-949
15. Benov L., and Batinić-Haberle I.A. manganese porphyrin suppresses oxidative stress and extends the life span of streptozotocin-diabetic rats. Free Radic. Res. 39 (2005) 81-88
16. Zhao Y., Chaiswing L., Oberley T.D., Batinić-Haberle I., St Clair W., Epstein C.J., and St Clair D. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res. 65 (2005) 1401-1405
17. Watanabe T., Owada S., Kobayashi H.P., Kawakami H., Nagaoka S., Murakami E., Ishiuchi A., Enomoto T., Jinnouchi Y., Sakurai J., Tobe N., Koizumi S., Shimamura T., Asakura T., Nakano H., and Otsubo T. Protective effects of MnM2Py4P and Mn-salen against small bowel ischemia/reperfusion injury in rats using an in vivo and an ex vivo electron paramagnetic resonance technique with a spin probe. Transplant. Proc. 39 (2007) 3002-3006
18. Day B.J. Antioxidants as potential therapeutics for lung fibrosis. Antioxid. Redox Signal. 10 (2008) 355-370
19. Doctrow S.R., Huffman K., Marcus C.B., Tocco G., Malfroy E., Adinolfi C.A., Kruk H., Baker K., Lazarowych N., Mascarenhas J., and Malfroy B. Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. J. Med. Chem. 45 (2002) 4549-4558
20. Spasojević I., Batinić-Haberle I., Stevens R.D., Hambright P., Thorpe A.N., Grodkowski J., Neta P., and Fridovich I. Manganese(III) biliverdin IX dimethyl ester: a powerful catalytic scavenger of superoxide employing the Mn(III)/Mn(IV) redox couple. Inorg. Chem. 40 (2001) 726-739
21. Musleh W., Bruce A., Malfroy B., and Baudry M. Effects of EUK-8, a synthetic catalytic superoxide scavenger, on hypoxia-and acidosis-induced damage in hippocampal slices. Neuropharmacology 33 (1994) 929-934
22. Vujaskovic Z., Batinić-Haberle I., Rabbani Z.N., Feng Q.F., Kang S.K., Spasojević I., Samulski T.V., Fridovich I., Dewhirst M.W., and Anscher M.S.A. small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic. Biol. Med. 33 (2002) 857-863
23. Langan A.R., Khan M.A., Yeung I.W., Van Dyk J., and Hill R.P. Partial volume rat lung irradiation: the protective/mitigating effects of Eukarion-189, a superoxide dismutase-catalase mimetic. Radiother. Oncol. 79 (2006) 231-238
24. Rabbani Z.N., Salahuddin F.K., Yarmolenko P., Batinic-Haberle I., Thrasher B.A., Gauter-Fleckenstein B., Dewhirst M.W., Anscher M.S., and Vujaskovic Z. Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation. Free Radic. Res. 41 (2007) 1273-1282
25. Gauter-Fleckenstein B., Fleckenstein K., Owzar K., Jiang C., Batinić-Haberle I., and Vujaskovic Z. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic. Biol. Med. 44 (2008) 982-989
26. van Empel V.P., Bertrand A.T., van Oort R.J., van der Nagel R., Engelen M., van Rijen H.V., Doevendans P.A., Crijns H.J., Ackerman S.L., Sluiter W., and De Windt L.J. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J. Am. Coll. Cardiol. 48 (2006) 824-832
27. Wang Z.Q., Porreca F., Cuzzocrea S., Galen K., Lightfoot R., Masini E., Muscoli C., Mollace V., Ndengele M., Ischiropoulos H., and Salvemini D.A. newly identified role for superoxide in inflammatory pain. J. Pharmacol. Exp. Ther. 309 (2004) 869-878
28. Riley D.P., Henke S.L., Lennon P.J., Weiss R.H., Neumann W.L., Rivers Jr. W.J., Aston K.W., Sample K.R., Rahman H., Ling C.S., Shieh J.J., Busch D.H., and Szulbinksi W. Synthesis, characterization, and stability of manganese(II) C-substituted 1,4,7,10,13-pentaazacyclopentadecane complexes exhibiting superoxide dismuting ability. Inorg. Chem. 35 (1996) 5213-5231
29. Huang T.T., Carlson E.J., Raineri I., Gillespie A.M., Kozy H., and Epstein C.J. The use of transgenic and mutant mice to study oxygen free radical metabolism. Ann. N. Y. Acad. Sci. 893 (1999) 95-112
30. Zhang X., Epperly M.W., Kay M.A., Chen Z.Y., Dixon T., Franicola D., Greenberger B.A., Komanduri P., and Greenberger J.S. Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene. Hum. Gene Ther. 19 (2008) 820-826
31. Yan S., Brown S.L., Kolozsvary A., Freytag S.O., Lu M., and Kim J.H. Mitigation of radiation-induced skin injury by AAV2-mediated MnSOD gene therapy. J. Gene Med. 10 (2008) 1012-1018
32. Liu J., Wang X., Wang F., Teng L., and Cao J. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro. Biomed. Pharmacother. (2008) [Electronic publication ahead of print].
33. Srinivasan V., Doctrow S., Singh V.K., and Whitnall M.H. Evaluation of EUK-189, a synthetic superoxide dismutase/catalase mimetic as a radiation countermeasure. Immunopharmacol. Immunotoxicol. 30 (2008) 271-290
34. 5+, targets mouse heart mitochondria. Free Radic. Biol. Med. 42 (2007) 1193-1200
35. Ferrer-Sueta G., Hannibal L., Batinic-Haberle I., and Radi R. Reduction of manganese porphyrins by flavoenzymes and submitochondrial particles: a catalytic cycle for the reduction of peroxynitrite. Free Radic. Biol. Med. 41 (2006) 503-512
36. Boder E. Ataxia-telangiectasia: an overview. In: Gatti R.A., and Swift M. (Eds). Ataxia-telangiectasia: Genetics, Neuropathology, and Immunology of a Degenerative Disease of Childhood (1985), A.R. Liss, New York 1-63
37. Gotoff S.P., Amirmokri E., and Liebner E.J. Ataxia telangiectasia: neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am. J. Dis. Child. 114 (1967) 617-625
38. Morgan J.L., Holcomb T.M., and Morrissey R.W. Radiation reaction in ataxia telangiectasia. Am. J. Dis. Child. 116 (1968) 557-558
39. Papageorgiou I., Paunier J.P., and Niederer J. Radiation therapy pneumonia. Radiol. Clin. Biol. 39 (1970) 256-261
40. Pollard, J.M.; Gatti, R.A. Clinical radiation sensitivity with DNA repair disorders: an overview. Int. J Radiat. Oncol. Biol. Phys. in press.
41. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
42. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald III E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., and Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
43. Bartek J., Bartkova J., and Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26 (2007) 7773-7779
44. Reichenbach J., Schubert R., Schindler D., Müller K., Böhles H., and Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 4 (2002) 465-469
45. Barzilai A., and Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amsterdam) 3 (2004) 1109-1115
46. Ambrose M., Goldstine J.V., and Gatti R.A. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum. Mol. Genet. 16 (2007) 2154-2164
47. Reboucas J.S., Spasojević I., and Batinić-Haberle I. Quality of Mn-porphyrin-based SOD mimics and peroxynitrite scavengers for preclinical mechanistic/therapeutic purposes. J. Pharm. Biomed. Anal. 48 (2008) 1046-1049
48. Aston K., Rath N., Naik A., Slomczynska U., Schall O.F., and Riley D.P. Computer-aided design (CAD) of Mn(II) complexes: superoxide dismutase mimetics with catalytic activity exceeding the native enzyme. Inorg. Chem. 40 (2001) 1779-1789
49. Archibald F.S., and Fridovich I. The scavenging of superoxide radical by manganous complexes: in vitro. Arch. Biochem. Biophys. 214 (1982) 452-463
50. Al-Maghrebi M., Fridovich I., and Benov L. Manganese supplementation relieves the phenotypic deficits seen in superoxide-dismutase-null Escherichia coli. Arch. Biochem. Biophys. 402 (2002) 109-140
51. Rogaku E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998) 5858-5868
52. 2 in cultured endothelial cells. Arch. Biochem. Biophys. 302 (1993) 348-355
53. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 142 (2004) 231-255
54. Sun X., Becker-Catania S.G., Chun H.H., Hwang M.J., Huo Y., Wang Z., Mitui M., Sanal O., Chessa L., Crandall B., and Gatti R.A. Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. J. Pediatr. 140 (2002) 724-731
55. Jiang F., Guo Y., Salvemini D., and Dusting G.J. Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Br. J. Pharmacol. 139 (2003) 1059-1060
56. Kamsler A., Daily D., Hochman A., Stern N., Shiloh Y., Rotman G., and Barzilai A. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61 (2001) 1849-1854
57. Yi M., Rosin M.P., and Anderson C.K. Response of fibroblast cultures from ataxia-telangiectasia patients to oxidative stress. Cancer Lett. 54 (1990) 43-50
58. Sheng, H.; Sakai, H.; Yang, W.; Fukuda, S.; Salahi, M.; Day, B. J.; Huang, J.; Paschen, W.; Batinic-Haberle, I.; Crapo, J. D.; Pearlstein, R. D.; Warner, D. S. Sustained treatment is required to produce long-term neuroprotective efficacy from a metalloporphyrin catalytic antioxidant in focal cerebral ischemia. Free Radic. Biol. Med. in press.
59. 5+in mitigation and treatment of radiation-induced lung damage. ASTRO and RRS Meeting, Boston, 2008 and Free Radic. Biol. Med. (Submitted for publication).
60. Batinic-Haberle I., Spasojevic I., Hambright P., Benov L., Crumbliss A.L., and Fridovich I. The relationship between redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vitro and in vivo superoxide dismutase activities of manganese(III) and iron(III) cationic and anionic porphyrins. Inorg. Chem. 38 (1999) 4011-4022
61. Murphy M.P. Targeting lipophilic cations to mitochondria. Biochim. Biophys. Acta 177 (2008) 1028-1031
62. Okado-Matsumoto A., Batinic-Haberle I., and Fridovich I. Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity. Free Radic. Biol. Med. 37 (2004) 401-410
63. Saba H., Batinić-Haberle I., Munusamy S., Mitchell T., Lichti C., Megyesi J., and MacMillan-Crow L.A. Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion. Free Radic. Biol. Med. 42 (2007) 1571-1578
64. Batinić-Haberle I., Ndengele M.M., Cuzzocrea S., Rebouças J.S., Spasojević I., and Salvemini D. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking morphine tolerance through peroxynitrite-mediated pathways. Free Radic. Biol. Med. 46 (2009) 212-219
65. Kos I., Reboucas J.S., DeFreitas-Silva G., Salvemini D., Vujaskovic Z., Dewhirst M.W., Spasojevic I., and Batinic-Haberle I. The effect of lipophilicity of porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridyl-porphyrins. Free Radic. Biol. Med. 47 (2009) 72-78
66. Dixon W.J., and Massey F.J. Introduction to Statistical Analysis. 4th ed (1983), New York, McGraw-Hill 428-439
67. Maroz A., Kelso G.F., Smith R.A.J., Ware D.C., and Anderson R.F. Pulse radiolysis investigation on the mechanism of the catalytic action of Mn(II)-pentaazamacrocycle compounds as superoxide dismutase mimics. J. Phys. Chem. 112 (2008) 4929-4935